News & Media

ImmunoQure AG Announces Publication in Cell of Naturally Occurring Patient-Derived Autoantibodies That Limit Human Diseases

ImmunoQure AG, a German biotechnology company focused on the development of autoantibodies as therapeutics to treat common human diseases today announced the publication of data in the leading scientific journal Cell, demonstrating that such therapeutics can limit a variety of common human diseases.